Home Journals Articles Updates About
CN
image
收藏切换
Research Progress of Traditional Chinese Medicine Targeting Nrf2 Signaling Pathway in Prevention and Treatment of Atherosclerosis
收藏切换
PDF
Liqiang SUN1, 2, 3, Zhengtao CHEN1, 2, 3, Jianguang WU1, 2, 3, Junyu LAI1, 2, 3, Zhongyong LIU1, 2, 3
Chinese Archives of Traditional Chinese Medicine | 2025, 43(12) : 172 - 182
Less
收藏切换
Chinese Archives of Traditional Chinese Medicine | 2025, 43(12): 172-182
• Target on National Project •
Research Progress of Traditional Chinese Medicine Targeting Nrf2 Signaling Pathway in Prevention and Treatment of Atherosclerosis
Full
Liqiang SUN1, 2, 3, Zhengtao CHEN1, 2, 3, Jianguang WU1, 2, 3, Junyu LAI1, 2, 3, Zhongyong LIU1, 2, 3
Affiliations
  • 1.Jiangxi University of Chinese Medicine，Nanchang 330004，Jiangxi，China
  • 2.Affiliated Hospital of Jiangxi University of Chinese Medicine，Nanchang 330006，Jiangxi，China
  • 3.Jiangxi Province Key Laboratory of Cardiovascular Diseases of Traditional Chinese Medicine，Nanchang 330006，Jiangxi，China
Published: 2025-12-10 doi: 10.13193/j.issn.1673-7717.2025.12.031
Outline
收藏切换

Atherosclerosis（AS）is a chronic and complex disease that occurs in the arterial wall and underlies a variety of cardiovascular pathologies.Nuclear factor erythroid 2-related factor 2（Nrf2）is an anti-oxidative stress high-sensitivity transcription factor that interacts with antioxidant response element（ARE）to activate downstream gene transcription and exerts various protective effects such as anti-inflammation，antioxidant and detoxification，thus protecting cellular components such as endothelial cells，macrophages，vascular smooth muscle cells，endothelial progenitor cells and so on in arterial vascular tissue，and plays an important role in the development of AS.Traditional Chinese medicine（TCM）has significant advantages in the treatment of AS due to its multi-targets and multi-pathways，stable efficacy，individualisation and safety.This article summarized the mechanism of Nrf2 regulation by TCM monomers，TCM extracts，TCM combinations and proprietary Chinese medicines in the prevention and treatment of AS，with a view to providing a theoretical basis for clinical research and drug development in the prevention and treatment of AS.

nuclear factor erythroid 2-related factor 2  /  atherosclerosis  /  traditional Chinesemedicine  /  pathogenesis
Liqiang SUN, Zhengtao CHEN, Jianguang WU, Junyu LAI, Zhongyong LIU. Research Progress of Traditional Chinese Medicine Targeting Nrf2 Signaling Pathway in Prevention and Treatment of Atherosclerosis[J]. Chinese Archives of Traditional Chinese Medicine, 2025 , 43 (12) : 172 -182 . DOI: 10.13193/j.issn.1673-7717.2025.12.031
Appendix
Less
Year 2025 volume 43 Issue 12
PDF
159
81
Cite this Article
BibTeX
Article Info
doi: 10.13193/j.issn.1673-7717.2025.12.031
  • Online Date：2026-04-29
  • Published：2025-12-10
Article Data
Affiliations
History
Funding
Affiliations
    1.Jiangxi University of Chinese Medicine，Nanchang 330004，Jiangxi，China
    2.Affiliated Hospital of Jiangxi University of Chinese Medicine，Nanchang 330006，Jiangxi，China
    3.Jiangxi Province Key Laboratory of Cardiovascular Diseases of Traditional Chinese Medicine，Nanchang 330006，Jiangxi，China
References
Share
https://castjournals.cast.org.cn/joweb/zhzyyxk/EN/10.13193/j.issn.1673-7717.2025.12.031
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House